Skip to main content

Bone Microenvironment Tissue Surrogates Engineered for Reporting of Metastasized Breast Cancer Osteolytic Activity

  • Jerald E. Dumas (a1), Akia N. Parks (a1) and Manu O. Platt (a1) (a2)

Breast cancer metastasis to bone continues to be a major clinical problem, and patient-to-patient variability in rates of disease progression and metastasis complicate treatment even further. This may be due to differences in the cancer cells, the osteoclasts, or the pre-metastatic niche, but all of these contribute to proteolytic remodeling necessary for osteolytic lesion establishment, primarily through secretion of cathepsin K, the most powerful human collagenase. There is debate about the relative contributions of breast cancer cells and osteoclasts and synergism between the two in altering the biochemical and biomechanical properties of the colonized bone, as these are difficult to parse with animal models. To quantify the relative contributions of breast cancer cells and osteoclasts in bone resorption, we have been developing engineered bone microenvironment tissue surrogates by adapting a poly(ester urethane) urea system embedded with microbone particles. Here, we report their use with MDA-MB-231 breast cancer cells and RAW264.7 derived osteoclasts, to provide temporal, multiscale reporters of bone resorption that can be measured non-destructively: 1) collagen degradation measured by C-terminal collagen fragment release, 2) mineral dissolution by measuring calcium released with the calcium arsenazo assay, and also show their beneficial effects in upregulating cathepsin K expression compared to tissue culture polystyrene controls. These more natural derived bone surrogates may be useful tools in mimicking bone metastatic niche and determining differences between proteolytic activity of different patients’ tumor and bone resident cells in a controlled manner.

Hide All
1. Cardoso, F. et al. ., Ann Oncol 13, 197 (2002).
2. Mundy, G. R., Nat Rev Cancer 2, 584 (2002).
3. Le Gall, C., et al. ., Cancer Res 67, 9894 (2007).
4. Littlewood-Evans, A. J. et al. ., Cancer Res 57, 5386 (1997).
5. Mundy, G. R., Nat Rev Cancer 2, 584 (2002).
6. Garnero, P. et al. ., J Biol Chem 273, 32347 (1998).
7. Le Gall, C., Bonnelye, E., Clezardin, P., Curr Opin Support Palliat Care 2, 218 (2008).
8. Desmarais, S., Masse, F., Percival, M. D., Biol Chem 390, 941 (2009).
9. Brubaker, K. D., Vessella, R. L., True, L. D., Thomas, R., Corey, E., J Bone Miner Res 18, 222 (2003).
10. Kleer, C. G. et al. ., Clin Cancer Res 14, 5357 (2008).
11. Li, W. A. et al. ., Anal Biochem 401, 91 (2010).
12. Chen, B., Platt, M. O., J Transl Med 9, 109 (2011).
13. Pelham, R. J. Jr., Wang, Y., Proc Natl Acad Sci U S A 94, 13661 (1997).
14. Peyton, S. R., Kim, P. D., Ghajar, C. M., Seliktar, D., Putnam, A. J., Biomaterials 29, 2597 (2008).
15. Deroanne, C. F., Lapiere, C. M., Nusgens, B. V., Cardiovasc Res 49, 647 (2001).
16. Wozniak, M. A., Desai, R., Solski, P. A., Der, C. J., Keely, P. J., J Cell Biol 163, 583 (2003).
17. Rowley, J. A., Madlambayan, G., Mooney, D. J., Biomaterials 20, 45 (1999).
18. Garnero, P. et al. ., J Bone Miner Res 18, 859 (2003).
19. Watts, N. B., Clinical Chemistry 45, 1359 (1999).
20. Lecaille, F., Bromme, D., Lalmanach, G., Biochimie 90, 208 (2008).
21. Wilder, C. L., Park, K. Y., Keegan, P. M., Platt, M. O., Archives of biochemistry and biophysics, (2011).
22. Platt, M. O. et al. ., Am J Physiol Heart Circ Physiol 292, H1479 (2007).
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

MRS Online Proceedings Library (OPL)
  • ISSN: -
  • EISSN: 1946-4274
  • URL: /core/journals/mrs-online-proceedings-library-archive
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 0
Total number of PDF views: 6 *
Loading metrics...

Abstract views

Total abstract views: 134 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 17th March 2018. This data will be updated every 24 hours.